Scott’s Story: Living with Lambert-Eaton Myasthenic Syndrome
November 15, 2023
Experience Scott’s extraordinary journey living with Lambert-Eaton myasthenic syndrome (LEMS), where for over a decade, he’s been his own advocate, navigating complex medical care. Watch the video to hear Scott share how Anovo championed his therapy needs, allowing he and his wife Jenny to focus on living life to the fullest.
“One of the great things about Anovo is that they’re specialists in not only my disease but also in the medication I take. Anovo did just a phenomenal job in managing the complexities of working with the specialty drug manufacturer, working with my insurance – that process has been absolutely one of the easiest experiences that I’ve ever had in my medical journey.”
Related Posts

How Anovo Builds Dedicated Teams to Support Your Rare Disease Therapy
At Anovo, we understand that complex rare disease therapies require high-touch service that large payer- and Pharmacy Benefit Manager-owned Specialty…
January 30, 2025

Justin’s Story: Living with Duchenne Muscular Dystrophy
When Justin was first diagnosed with Duchenne muscular dystrophy, his parents, Amanda and Andrew, weren’t sure how to navigate the…
January 14, 2025

Eton Pharmaceuticals & Anovo Partner to Expand Access for Patients with Severe Primary Insulin-Like Growth Factor 1 Deficiency
Eton Pharmaceuticals is dedicated to developing and commercializing treatments for rare diseases, with a strong focus on pediatric endocrinology. Their…
December 20, 2024